Hypophosphataemic rickets after ifosfamide treatment in children.-Reference-Cited by-同舟云学术

Hypophosphataemic rickets after ifosfamide treatment in children.

Published:1989-06-10 Issue:6687 Volume:298 Page:1560-1561
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Skinner R.,Pearson A. D.,Price L.,Cunningham K.,Craft A. W.

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference5 articles.

1. Unexpected toxicity in patients treated with iphosphamide;JJ, Van Dyk; HC, Falkson; van der Merve AM; G, Falkson;Cancer Res,1972

2. Renal dysfunction after treatment with isophosphamide (NSC-109724);RA, De Fronzo; M, Abeloff; H, Braine; RL, Humphrey; PJ, Davis;Cancer ChemotherRep,1974

3. Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity;Sangster, G.; Kaye, S.B.; Calman, K.C.; Dalton, J.F.;EurJ Cancer Clin Oncol,1984

4. A phase II study of ifosfamide in children with recurrent solid tumours;H, Pinkerton C.R.Rogers; C, James;Cancer Chetnother Pharmacol,1985

5. Toxicity of high dose ifosfamide in children;Davies, S.M.; Pearson, A.D.J.; Craft, A.W.;Cancer Chemother Pharmacol

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone complications of cancer treatment;Cancer Treatment Reviews;2024-11

2. Osteosarcoma-Approach to Therapy;Sarcomas of Bone and Soft Tissues in Children and Adolescents;2020-10-02

3. Renal toxicity and chemotherapy in children with cancer;British Journal of Clinical Pharmacology;2017-09-20

4. Interleukin 18 as a Marker of Chronic Nephropathy in Children after Anticancer Treatment;Disease Markers;2013

5. Low Bone Mineral Density and High Incidences of Fractures and Vitamin D Deficiency in 52 Pediatric Cancer Survivors;Hormone Research in Paediatrics;2010